We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,651.50
Bid: 1,651.00
Ask: 1,651.50
Change: 0.50 (0.03%)
Spread: 0.50 (0.03%)
Open: 1,656.50
High: 1,661.50
Low: 1,650.00
Prev. Close: 1,651.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Europe down but oil and mining stocks boost FTSE

Wed, 23rd Jun 2021 12:11

(Alliance News) - The FTSE 100 climbed midday Wednesday, with share price gains for miners and oil stocks ensuring the London's blue-chip index outperformed continental peers, following a raft of mixed PMI readings across the globe.

"Experiences throughout Australia, Japan, and Europe highlight a tough June after many surveys fell short. From a UK perspective, the decline in services growth is worrying, with exports falling for the second-consecutive month," IG market analyst Joshua Mahony commented.

"From a UK perspective, the decline in services growth is worrying, with exports falling for the second-consecutive month. One common theme appears to be the impact of rising prices, with input costs rising at the fastest pace in 13 years."

The FTSE 100 index was up 24.87 points, or 0.4%, at 7,114.88 on Wednesday at midday. The mid-cap FTSE 250 index was up just 8.18 points 22,687.82. The AIM All-Share index was up 2.70 points, or 0.2%, at 1,224.85.

The Cboe UK 100 index was up 0.3% at 708.55. The Cboe 250 was 0.1% higher at 20,378.93, and the Cboe Small Companies up 0.4% at 15,348.99.

The UK's flash composite output index, a weighted average of the services and manufacturing readings, remained above the 50.0 no-change mark but fell to a two-month low of 61.7 points in June, from May's 62.9 tally.

Earlier figures showed Japan's private sector remained in contraction, though the eurozone's flash composite PMI increased to 59.2 in June from 57.1 in May, its highest since June 2006.

The pound was quoted at USD1.3967 midday Wednesday following the PMI data, up from USD1.3927 at the London equities close on Tuesday. The euro stood at USD1.1946, up from USD1.1905.

In mainland Europe, the CAC 40 in Paris was down 0.4%, while the DAX 30 in Frankfurt was down 0.5%.

The luxury retail sector held back the blue-chip benchmark in Paris. Kering was down 2.6%, Hermes International 1.6% lower and LVMH fell 1.3%.

In London, Burberry was down 0.1% after HSBC cut the stock to Hold from Buy.

Brent oil was quoted at USD75.44 a barrel, up from USD74.91.

ActivTrades analyst Pierre Veyret explained: "Most oil traders are also paying attention to the ongoing talks with Iran where an agreement with another superpower could quickly lead to a flood in global supply and seriously dent the current rally. Investors will also keep an eye on today's US crude oil inventories where a significant increase is widely expected."

Royal Dutch Shell A shares rose 1.8% in London and the oil major's B stock was up 1.9%. In addition, Societe Generale raised Shell's A shares to Buy from Hold. Peer BP was trading 1.3% higher.

Rio Tinto climbed 1.0%, Anglo American was up 1.1% and BHP rose 0.7% during a largely positive session for the mining sector.

Phoenix Group shares fell 3.3% to 670.20p, the worst blue-chip performer in London. Swiss Re said it has sold a 6.6% stake in Phoenix Group for GBP437 million, offloading half the stake it acquired after selling its ReAssure Group subsidiary to Phoenix last summer.

Swiss Re sold 66.2 million shares at 660p each, and will hold a 6.6% stake following completion of the sale. Prior to the transaction, Swiss Re held a near 13.3% stake in Phoenix Group.

Phoenix was not a party to the placing and will not receive any proceeds.

As Swiss Re's stake has fallen below 10%, it no longer has the right to appoint a non-executive director to the Phoenix board, the FTSE 100-listed long-term savings and retirement business noted. As a result, Christopher Minter will resign from the Phoenix board with effect from the share sale settlement, expected to be around June 25.

The housebuilding sector was lower. Barratt Developments fell 1.7%, Taylor Wimpey gave back 1.4% and Persimmon fell 1.6%.

The UK Competition & Markets Authority said Persimmon and insurer Aviva have committed to refund leasehold homeowners following an industry probe.

Persimmon will allow homeowners to buy the freehold of their home at a discount, while Aviva will remove certain clauses from leasehold contracts and repay those who were affected by them, the regulator said.

Persimmon said all homeowners who have bought a leasehold property since 2000 will be allowed to buy their freehold, for a price capped at GBP2,000. The company also will reimburse customers who already bought their freehold for more than GBP2,000 under an existing scheme.

Aviva, which buys leasehold contracts from housebuilders, has agreed to remove "doubling clauses" and refund those who were affected by them. It will also end ground rents that rise with inflation, meaning those rents will revert to their original price.

Aviva shares were 0.1% lower.

Berkeley fell 1.8%, despite reporting improved annual earnings. The housebuilder cautioned transaction levels in its key London market were hit by travel restrictions and Berkeley's selective approach to market, but was confident as enquiries in the UK capital are now above pre-pandemic levels.

Berkeley's pretax profit in the year ended April 30 was 2.9% higher at GBP518.1 million from GBP503.7 million. Revenue rose 15% to GBP2.20 billion from GBP1.92 billion.

GlaxoSmithKline shares were on the rise, up 1.6%. The pharmaceutical firm outlined a new strategic focus, plans to boost sales and profit in the medium term and a fresh "progressive dividend policy".

In an investor update, GSK said it plans to achieve GBP33 billion in sales by the end of 2031. Over the next five years, it is eyeing a sales climb of more than 5% and more than a 10% hike in adjusted operating profit.

It added it will retain a 20% stake in its upcoming Consumer Healthcare spin-out, a "short-term financial investment, which it intends to monetise in a timely manner".

New York equities are called higher, building on Tuesday's gains. The Dow Jones Industrial Average is called up 0.2%, and both the S&P 500 and Nasdaq Composite are pointed up 0.1%. Federal Reserve Chair Jerome Powell on Tuesday suggested the central bank will only patiently rein in its vast monetary policy support.

Powell stuck to his prepared script during the House hearing and reiterated that the central bank will continue its supportive stance to ensure that the "sustained improvement" since the depths of Covid-19 pandemic is extended.

BDSwiss head of investment research, Marshall Gittler, commented: "Powell didn't say anything different from what he said in his comments after the FOMC meeting: most of the rise in inflation is due to transitory effects arising from the reopening of the economy, but these effects have been larger than they expected and could turn out to be more persistent. He emphasized that the FOMC 'will wait for actual evidence of actual inflation or other imbalances' before hiking rates and not move in response to projections."

Against the yen, the dollar was trading at JPY111.04, up from JPY110.73.

Gold was trading at USD1,783.29 an ounce midday on Wednesday, up against USD1,780.60 late Tuesday.

Wednesday afternoon's economic calendar has the US flash PMI for June at 1445 BST, before new home sales at 1500 BST.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
Today 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more
16 Apr 2024 09:17

GSK meningococcal vaccine accepted by US FDA for review

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

Read more
16 Apr 2024 08:59

GSK's latest meningitis vaccine accepted for review by US regulator

(Alliance News) - GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths of two other vaccines in its portfolio into one bacteria-fighting inoculation.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
9 Apr 2024 11:45

Pfizer RSV shot meets goals in trial of high-risk adults under age 60

April 9 (Reuters) - Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults, for whom the shot is already approved.

Read more
8 Apr 2024 09:13

LONDON BROKER RATINGS: Wizz Air raised; HSBC cuts Rentokil to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
4 Apr 2024 13:08

UK dividends calendar - next 7 days

Friday 5 April 
BBGI Global Infrastructure SAdividend payment date
Molten Ventures PLCdividend payment date
Pennon Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
Regional REIT Ltddividend payment date
Rights & Issues Investment Trust PLCdividend payment date
Sylvania Platinum Ltddividend payment date
Titon Holdings PLCdividend payment date
Triple Point Energy Transition PLCdividend payment date
Monday 8 April 
Alumasc Group PLCdividend payment date
LondonMetric Property PLCdividend payment date
Redrow PLCdividend payment date
Tuesday 9 April 
CT Global Managed Portfolio Trust PLCdividend payment date
Downing Strategic Micro-Cap Investment Trust PLCdividend payment date
Dunelm Group PLCspecial dividend payment date
Hays PLCdividend payment date
Renishaw PLCdividend payment date
Safestore Holdings PLCdividend payment date
Wednesday 10 April 
Assura PLCdividend payment date
Primorus Investments PLCspecial dividend payment date
Wilmington PLCdividend payment date
Thursday 11 April 
Amedeo Air Four Plus Ltdex-dividend payment date
Athelney Trust PLCdividend payment date
Aviva PLCex-dividend payment date
Balanced Commercial Property Trust Ltdex-dividend payment date
Barratt Developments PLCex-dividend payment date
Begbies Traynor Group PLCex-dividend payment date
Bioventix PLCex-dividend payment date
Blackfinch Spring VCT PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
Caledonia Mining Corpex-dividend payment date
Capital & Regional PLCex-dividend payment date
Chesnara PLCex-dividend payment date
Colefax Group PLCdividend payment date
CT Private Equity Trust PLCex-dividend payment date
Downing Strategic Micro-Cap Investements Trust PLCex-dividend payment date
Driver Group PLCdividend payment date
F&C Investment Trust PLCex-dividend payment date
Foxtons Group PLCex-dividend payment date
Grafton Group PLCex-dividend payment date
GSK PLCdividend payment date
Harbour Energy PLCex-dividend payment date
Hargreaves Services PLCdividend payment date
Howden Joinery Group PLCex-dividend payment date
Hunting PLCex-dividend payment date
i3 Energy PLCex-dividend payment date
International Personal Finance PLCex-dividend payment date
International Public Partnerships Ltdex-dividend payment date
ITV PLCex-dividend payment date
Johnson Service Group PLCex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Japan Small Cap Growth & Income PLCex-dividend payment date
Just Group PLCex-dividend payment date
Kenmare Resources PLCex-dividend payment date
Kerry Group PLCex-dividend payment date
Kings Arms Yard VCT PLCex-dividend payment date
Law Debenture Corp PLCdividend payment date
Lloyds Banking Group PLCex-dividend payment date
Lowland Investment Cos PLCex-dividend payment date
Luceco PLCex-dividend payment date
Man Group PLCex-dividend payment date
Manchester & London Investement Trust PLCex-dividend payment date
Marble Point Loan Financing Ltdex-dividend payment date
Mercantile Investment Trust PLCex-dividend payment date
Mobius Investment Trust PLCex-dividend payment date
MTI Wireless Edge Ltddividend payment date
North American Income Trust PLCex-dividend payment date
Northamber PLCex-dividend payment date
Octopus Apollo VCT PLCex-dividend payment date
Phoenix Group Holdings PLCex-dividend payment date
Reckitt Benckiser Group PLCex-dividend payment date
Ricardo PLCdividend payment date
Savills PLCex-dividend payment date
Schroder Asian Total Return Investment Cos PLCex-dividend payment date
Schroder European Real Estate Investment Trust PLCex-dividend payment date
Scottish American Investment Cos PLCdividend payment date
Smurfit Kappa Group PLCex-dividend payment date
Softcat PLCex-dividend payment date
Somero Enterprises Incex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Synectics PLCex-dividend payment date
TP ICAP Group PLCex-dividend payment date
Trifast PLCdividend payment date
TT Electronics PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
4 Apr 2024 00:03

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK, April 3 (Reuters) - Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.